关注
Dr. LALIT KUMAR [D.P.M.M., M. PHARM. (Pharmaceutics), Ph.D.]
Dr. LALIT KUMAR [D.P.M.M., M. PHARM. (Pharmaceutics), Ph.D.]
Professor (Pharmaceutics), GNA University, Sri Hargobindgarh, Phagwara-Hoshiarpur Road, Phagwara
在 gnauniversity.edu.in 的电子邮件经过验证
标题
引用次数
引用次数
年份
Advanced Drug Delivery Systems for Transdermal Delivery of Non-Steroidal Anti-Inflammatory Drugs: A Review
PU Lalit Kumar, Shivani Verma, Mehakjot Singh, Tamanna Tamanna
Current Drug Delivery, 2018
942018
Eradication of superficial fungal infections by conventional and novel approaches: a comprehensive review
L Kumar, S Verma, A Bhardwaj, S Vaidya, B Vaidya
Artificial cells, nanomedicine, and biotechnology 42 (1), 32-46, 2014
772014
Oleic acid vesicles: a new approach for topical delivery of antifungal agent
S Verma, A Bhardwaj, M Vij, P Bajpai, N Goutam, L Kumar
Artificial cells, nanomedicine, and biotechnology 42 (2), 95-101, 2014
752014
Nanotechnology: a magic bullet for HIV AIDS treatment
L Kumar, S Verma, DN Prasad, A Bhardwaj, B Vaidya, AK Jain
Artificial cells, nanomedicine, and biotechnology 43 (2), 71-86, 2015
662015
Development and characterization of ligand-appended liposomes for multiple drug therapy for pulmonary tuberculosis
A Bhardwaj, L Kumar, RK Narang, RSR Murthy
Artificial cells, nanomedicine, and biotechnology 41 (1), 52-59, 2013
542013
Ethanol based vesicular carriers in transdermal drug delivery: nanoethosomes and transethosomes in focus
C Nicolini
NanoWorld journal 1 (2), 2016
492016
Exosomes: natural carriers for siRNA delivery
L Kumar, S Verma, B Vaidya, V Gupta
Current pharmaceutical design 21 (31), 4556-4565, 2015
412015
Stimuli-sensitive Systems-an emerging delivery system for drugs
A Bhardwaj, L Kumar, S Mehta, A Mehta
Artificial cells, nanomedicine, and biotechnology 43 (5), 299-310, 2015
382015
Formulation and Characterization of Transethosomes for Enhanced Transdermal Delivery of Propranolol Hydrochloride
PU Lalit Kumar
Micro and Nanosystems, 2019
35*2019
Fatty acid vesicles acting as expanding horizon for transdermal delivery
L Kumar, S Verma, S Kumar, DN Prasad, AK Jain
Artificial cells, nanomedicine, and biotechnology 45 (2), 251-260, 2017
312017
Nanofiber as a novel vehicle for transdermal delivery of therapeutic agents: challenges and opportunities
PUSS Lalit Kumar, Shivani Verma, Kajal Joshi
Future Journal of Pharmaceutical Sciences, 175, 2021
232021
Nanotechnological Carriers for Treatment of Acne.
LK Shivani Verma, Puneet Utreja
Recent Patents on Anti-Infective Drug Discovery 13 (2), 105-126, 2018
20*2018
Polymeric microparticles-based formulation for the eradication of cutaneous candidiasis: development and characterization
L Kumar, S Verma, S Jamwal, S Vaidya, B Vaidya
Pharmaceutical development and technology 19 (3), 318-325, 2014
192014
Bioadhesive Polymers for Targeted Drug Delivery
L Kumar, S Verma, B Vaidya, V Gupta
Nanotechnology-Based Approaches for Targeting and Delivery of Drugs and …, 2017
172017
Nanocarriers assisted antimicrobial therapy against intracellular pathogens
L Kumar, S Verma, B Vaidya, NK Mehra
Nanostructures for antimicrobial Therapy 13, 293-324, 2017
142017
Gold nanoparticles and their applications in cancer treatment
S Verma, P Utreja, M Rahman, L Kumar
Current Nanomedicine, 2018
132018
Asymmetric membrane capsule (AMC): an useful osmotic drug delivery system
L Kumar, KA Shivani, D Parashar, S Bhadra
Int J Pharm Pharm Sci 4 (2), 54-59, 2012
132012
Liposomes for the delivery of streptokinase
L Kumar, S Verma, B Vaidya
Therapeutic Delivery 8 (10), 855-866, 2017
102017
Overview of inorganic nanoparticles: An expanding horizon in tumor therapeutics
DK Lalit Kumar, Shivani Verma , Puneet Utreja
Recent patents on anti-cancer drug discovery, 10.2174/1574892817666221005094423, 2022
7*2022
Optimisation of a Greener-Approach for the Synthesis of Cyclodextrin-Based Nanosponges for the Solubility Enhancement of Domperidone, a BCS Class II Drug
M Vij, D Neha, K Lalit, W Pankaj, UDW Shahid, M Wael A., A Sultan, ...
Pharmaceuticals 16 (4), 567, 2023
62023
系统目前无法执行此操作,请稍后再试。
文章 1–20